These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2488913)

  • 1. [Incidence of cefotetan sensitivity in anaerobic microbes responsible for acute and chronic relapsing bronchopneumonia].
    Guarino C; Cautiero V; Tarantino C; Cuccurullo S; Cione B; Marcatili A
    G Ital Chemioter; 1989; 36(1-3):53-6. PubMed ID: 2488913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cefotetan treatment of suppurative bronchopulmonary syndromes sustained by anaerobic germs].
    Caputi M; Guarino C; Cautiero V; Sorrentino L; Cione P; Cuccurullo S; Tarantino C
    Arch Monaldi Mal Torace; 1990; 45(5):401-10. PubMed ID: 2152338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aerobic and anaerobic bacterial flora as a cause of lower respiratory tract infection].
    Rylski M; Stelmaska-Dworak E; Andrzejewski K
    Pneumonol Alergol Pol; 1993; 61(3-4):144-7. PubMed ID: 8364428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative in vitro activity of cefoxitin vs. cefotetan against clinical isolates of Bacteroides and Prevotella species.
    Grossmeyer TJ; Farmer SG
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S353-6. PubMed ID: 8324146
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
    Cruciani M; Navarra A; Bono L; Concia E
    Chemioterapia; 1988 Aug; 7(4):261-3. PubMed ID: 3180306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
    Cruciani M; Navarra A; Bono L; Concia E
    J Chemother; 1989 Jul; 1(4 Suppl):101-2. PubMed ID: 16312323
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of predictability of cefotetan in vitro susceptibility tests against cefotetan-resistant anaerobic bacteria in determining clinical and bacteriologic efficacies.
    Sheikh W; Bobey DG
    Diagn Microbiol Infect Dis; 1992; 15(7):595-600. PubMed ID: 1424516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide assessment of the activity of cefotetan against clinical isolates.
    Turner PJ; Edwards JR
    J Chemother; 1989 Jul; 1(4 Suppl):97-8. PubMed ID: 16312321
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence and role of anaerobic flora in local and systemic infections in childhood.
    Bittner J; Munteanu V; Ardeleanu J; Antohi M; Macovei A; Lemeni D; Gheorghe V; Popescu A; Popescu E; Ciucă T
    Arch Roum Pathol Exp Microbiol; 1988; 47(2):93-7. PubMed ID: 3250368
    [No Abstract]   [Full Text] [Related]  

  • 11. [A microbiological evaluation of the use of roxithromycin in oral odontogenic infections].
    Lo Bue AM; Chisari G; Caruso S; Gismondo MR
    Minerva Stomatol; 1993; 42(7-8):355-60. PubMed ID: 8295624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anaerobic bacteria in various infections and their antibiotic susceptibility patterns].
    Tunçkanat F; Günalp A
    Mikrobiyol Bul; 1986 Oct; 20(4):230-41. PubMed ID: 3657617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiology of acute purulent pericarditis. A 12-year experience in a military hospital.
    Brook I; Frazier EH
    Arch Intern Med; 1996 Sep; 156(16):1857-60. PubMed ID: 8790081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study of the antibacterial activity of cefotetan compared with piperacillin and ceftriaxone against bacterial strains isolated from pathological material of hospital patients.
    Gatti M; Varoli O; Piscolla F
    J Chemother; 1989 Jul; 1(4 Suppl):103-4. PubMed ID: 16312324
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
    Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
    Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aerobic and anaerobic bacterial flora in chronic sinusitis in adults].
    Radosz-Komoniewska H; Kapp-Burzyńska Z; Kłaptocz B; Wilk I; Ekiel A
    Med Dosw Mikrobiol; 1997; 49(1-2):89-94. PubMed ID: 9411078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
    Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
    J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of anaerobic bacteria in sinusitis.
    Brook I
    Anaerobe; 2006 Feb; 12(1):5-12. PubMed ID: 16701606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of fungal and bacterial infections of the diabetic foot.
    Chincholikar DA; Pal RB
    Indian J Pathol Microbiol; 2002 Jan; 45(1):15-22. PubMed ID: 12593559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.